Odisha Govt Signs MoU with NDDB to Set up new GMP facility to Produce Anthrax & ENT Vaccines?

MOUs and Agreement

The MoU was signed by Ramashis Hazra, Director of Animal Husbandry and Veterinary Services (AH&VS) from Odisha, and Sunil Sinha, Senior General Manager from NDDB. This project, aligned with the state's 5-T Charter for transformative healthcare and disease management in livestock and poultry, aligns with the state's commitment to improving animal health.Currently, the OBPI's satellite unit in Berhampur produces 22 lakh doses of Anthrax Spore Vaccine (ASV) and 14 lakh doses of Enterotoxaemia Vaccine (ENTV) annually using conventional methods. The new GMP facility, adhering to WHO and Indian regulatory standards, will significantly increase production and ensure world-class quality vaccines.With the GMP facility operational, annual production is expected to reach 2 crore doses of ASV and 50 lakh doses of ENTV. This ambitious project involves an investment of Rs. 52 crore, with NDDB providing crucial consultancy and support throughout the setup process.


      The GMP facility is for the production of Anthrax and Enterotoxaemia (ENT) vaccines at the Satellite Unit of Odisha Biological Products Institute (OBPI) in Berhampur

      The project is estimated with an investment of Rs 52.20 crore for the production of these vaccines.

      The construction work of the laboratory will be completed within 36 months.

 

     


About Odisha:

Chief Minister– Naveen Patnaik, Governor– Raghubar Das
Tiger Reserve– Similipal Tiger Reserve and Satkosia Tiger Reserve, Wildlife Sanctuary– Satkosia Gorge sanctuary (Angul) and Nandankanan sanctuary (Bhubaneswar)
          ____________________________